Support levels were shredded across the board. By the closing bell four of the five major indices had closed below their respective 50-day moving averages. The small-cap Russell 2000 (NYSE:IWM) led the plummet as it lost a whopping 3.0% yesterday. The S&P MidCap 400 and the Nasdaq (NASDAQ:QQQ) plunged 2.8% and 2.7% respectively. The S&P 500 (NYSE:SPY) fell 2.0% while the Dow Jones Industrial Average (NYSE:DIA) showed the most resiliency but still shed over 1.5% on the session.
Day over day market internals went from bad to abysmal. Volume surged by 35.0% on the Nasdaq and 27.5% on the Big Board. Declining volume overwhelmed advancing volume by a factor of 16 to 1 on the NYSE and 11 to 1 on the Nasdaq. Institutional investors were clearly seeking refuge from the stock market as the day’s selloff resulted in over 600 stocks dropping 4% or more in value. Wednesday was both a follow-through and a distribution day for the market.
Given the breadth of yesterday’s selling, a review of major indices is in order. Following powerful advances or declines in the broad market it is generally a good idea to take a step back and identify key support and resistance levels in order to plan for the next possible trading opportunities. A quick glance at the follow charts of the S&P 500, Nasdaq, Dow Jones Industrial Average, S&P MidCap 400 and small-cap Russell 2000 provides important information about support and resistance levels on each of these indices (dashed horizontal blue lines) . Notice the size of the reversal candles (highlighted in light blue) as each index failed to break above key resistance. When a stock, index or ETF forms a massive reversal candle it will often mark an intermediate or long term top/bottom.
It is also noteworthy that leadership stocks and ETFs began showing relative weakness over the past two sessions. When a market is under pressure, the good often gets thrown out with the bad. For example strong sectors such as retail (NYSE:XRT), biotechnology (NYSE:IBB), medical devices (NYSE:IHI) and pharmaceuticals (NYSE:PPH) have come under severe selling pressure in the past two days. In yesterday’s newsletter we even mentioned XRT as a possible long candidate. Needless to say, XRT sold off sharply yesterday. When long term leaders become laggards it is not usually a good sign for the broad market.
Until yesterday the pundits were claiming that the market was not overly concerned about the debt and deficit debate in Washington. With yesterday’s dismal performance now on the books, maybe this can serve as a catalyst to prompt Washington to find a resolution a little bit quicker.
Deron Wagner is the Founder and Head Portfolio Manager of Morpheus Trading Group, a capital management and trader education firm launched in 2001. Wagner is the author of the best-selling book, Trading ETFs: Gaining An Edge With Technical Analysis (Bloomberg Press, August 2008), and also appears in the popular DVD video, Sector Trading Strategies (Marketplace Books, June 2002). He is also co-author of both The Long-Term Day Trader (Career Press, April 2000) and The After-Hours Trader (McGraw Hill, August 2000). Past television appearances include CNBC, ABC, and Yahoo! FinanceVision. Wagner is a frequent guest speaker at various trading and financial conferences around the world, and can be reached by sending e-mail to: email@example.com.
DISCLAIMER: There is a risk for substantial losses trading securities and commodities. This material is for information purposes only and should not be construed as an offer or solicitation of an offer to buy or sell any securities. Morpheus Trading, LLC (hereinafter “The Company”) is not a licensed broker, broker-dealer, market maker, investment banker, investment advisor, analyst or underwriter. This discussion contains forward-looking statements that involve risks and uncertainties. A stock’s actual results could differ materially from descriptions given. The companies discussed in this report have not approved any statements made by The Company. Please consult a broker or financial planner before purchasing or selling any securities discussed in The Wagner Daily (hereinafter “The Newsletter”). The Company has not been compensated by any of the companies listed herein, or by their affiliates, agents, officers or employees for the preparation and distribution of any materials in The Newsletter. The Company and/or its affiliates, officers, directors and employees may or may not buy, sell or have positions in the securities discussed in The Newsletter and may profit in the event the shares of the companies discussed in The Newsletter rise or fall in value. Past performance never guarantees future results.